Munafa Stock Market Course + Intraday & FNO calls 
Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 15 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 341.63 and Closed at: 333.39, which is -1.81% of previous session's close. It moved within a range of 331.02 and 342.23
The session was a Bearish session with an average volume of 799000, which is -53.77% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 9 days back on short term averages
A Golden cross was found 2 days back on mid term averages
Support for tomorrow is 326.6 and resistance for tomorrow is 337.81
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 328.86, 324.34 resistance for tomorrow's hourly charts is 340.07, 346.76
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 327.39 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 322.68 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 325.17 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 364.23 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 393.96 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 322.68 and 200 DMA is at 393.96, while 50 DMA and 100 DMA are at 325.17 and 364.23 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 322.68 and 20 EMA is at 325.91
| Date | Closing Price | 20 SMA | 20 EMA |
| 15 Wed Apr | 333.39 | 322.68 | 325.91 |
| 14 Tue Apr | 339.41 | 321.96 | 325.12 |
| 13 Mon Apr | 333.00 | 320.66 | 323.62 |
| 10 Fri Apr | 322.11 | 319.87 | 322.63 |
| 09 Thu Apr | 321.28 | 319.78 | 322.69 |
| 08 Wed Apr | 327.25 | 319.9 | 322.84 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 325.17 and 50 EMA is at 333.93
| Date | Closing Price | 50 SMA | 50 EMA |
| 15 Wed Apr | 333.39 | 325.17 | 333.93 |
| 14 Tue Apr | 339.41 | 325.26 | 333.95 |
| 13 Mon Apr | 333.00 | 325.41 | 333.73 |
| 10 Fri Apr | 322.11 | 325.74 | 333.76 |
| 09 Thu Apr | 321.28 | 326.4 | 334.24 |
| 08 Wed Apr | 327.25 | 327.2 | 334.77 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 364.23 and 100 EMA is at 353.82
| Date | Closing Price | 100 SMA | 100 EMA |
| 15 Wed Apr | 333.39 | 364.23 | 353.82 |
| 14 Tue Apr | 339.41 | 365.5 | 354.23 |
| 13 Mon Apr | 333.00 | 366.6 | 354.53 |
| 10 Fri Apr | 322.11 | 367.81 | 354.96 |
| 09 Thu Apr | 321.28 | 369.12 | 355.62 |
| 08 Wed Apr | 327.25 | 370.42 | 356.31 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 393.96 and 200 EMA is at 359.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 15 Wed Apr | 333.39 | 393.96 | 359.94 |
| 14 Tue Apr | 339.41 | 393.88 | 360.21 |
| 13 Mon Apr | 333.00 | 393.79 | 360.42 |
| 10 Fri Apr | 322.11 | 393.75 | 360.7 |
| 09 Thu Apr | 321.28 | 393.71 | 361.09 |
| 08 Wed Apr | 327.25 | 393.65 | 361.49 |
Alnylam Pharmaceuticals has performed better than U S in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Universal Health in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Arcus Biosciences has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Arcus Biosciences, about 0.86% more returns!
Alnylam Pharmaceuticals has performed better than Hca Healthcare in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Boston Scientific in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Avanos Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Avanos Medical, about 77.58% more returns!
Alnylam Pharmaceuticals has performed better than Abbott Laboratories in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Vanda Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Staar Surgical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Staar Surgical, about 34.49% more returns!
Surgery Partners has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Surgery Partners, about 0.46% more returns!
Intellia Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 6.7% more returns!
Alnylam Pharmaceuticals has performed better than Minerva Neurosciences in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Neogenomics Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Neogenomics Inc, about 0.91% more returns!
Hutchison China has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Hutchison China, about 2.94% more returns!
Alnylam Pharmaceuticals has performed better than Genprex Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 6.87% more returns!
Aptevo Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 12.36% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Alnylam Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Alnylam Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 327.52 and Alnylam Pharmaceuticals ALNY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
